Virtus ETF Advisers’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,296
| Closed | -$346K | – | 382 |
|
|
2024
Q4 | $346K | Buy |
27,296
+1,805
| +7% | +$22.9K | 0.14% | 205 |
|
|
2024
Q3 | $355K | Hold |
25,491
| – | – | 0.17% | 214 |
|
|
2024
Q2 | $351K | Buy |
25,491
+19,413
| +319% | +$268K | 0.17% | 198 |
|
|
2024
Q1 | $100K | Sell |
6,078
-414
| -6% | -$6.84K | 0.05% | 363 |
|
|
2023
Q4 | $94.8K | Sell |
6,492
-847
| -12% | -$12.4K | 0.06% | 384 |
|
|
2023
Q3 | $90.1K | Sell |
7,339
-734
| -9% | -$9.01K | 0.05% | 348 |
|
|
2023
Q2 | $96.4K | Buy |
8,073
+3,388
| +72% | +$40.5K | 0.06% | 401 |
|
|
2023
Q1 | $62.6K | Sell |
4,685
-1,797
| -28% | -$24K | 0.03% | 421 |
|
|
2022
Q4 | $139K | Sell |
6,482
-119
| -2% | -$2.56K | 0.07% | 367 |
|
|
2022
Q3 | $132K | Buy |
6,601
+50
| +0.8% | +$1K | 0.05% | 375 |
|
|
2022
Q2 | $117K | Sell |
6,551
-2,335
| -26% | -$41.7K | 0.04% | 391 |
|
|
2022
Q1 | $88K | Sell |
8,886
-527
| -6% | -$5.22K | 0.04% | 320 |
|
|
2021
Q4 | $159K | Buy |
+9,413
| New | +$159K | 0.06% | 327 |
|